Veracyte (VCYT) Stock Price, Quote, News & History | Benzinga

Veracyte Inc (VCYT) Stock Price, Quote, News & History

VCYTNASDAQ

Trade with Public

Trade with Public

$41.52

-0.79-1.86%

Last update: Aug 24, 12:50 PM

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Ownership Compare Options Stock Report

Key Statistics

Open

$42.00

Close

-

Volume / Avg.

397.69K / 1.33M

Day Range

$41.04 - $42.07

52 Wk Range

28.25 - 60.91

Market Cap

$3.31B

P/E Ratio

30.22

Dividend Yield

-

Exchange

NASDAQ

RSI

34

Short Interest

10.17%

Days to Cover

4.81

Recent Veracyte, Inc. News

Top 3 Health Care Stocks That Could Blast Off This Month

The health care sector's oversold stocks present buying opportunities for undervalued companies. RSI compares stock strength on up and down days, with an RSI below 30 considered oversold.

Avi Kapoor

Apple, Stryker, Coinbase And Other Big Stocks Moving Lower In Friday’s Pre-Market Session

U.S. stock futures rise, Nasdaq 100 up 300 points. Apple Inc shares fall 7.4% despite beating analyst estimates for Q3. Other stocks also dip in pre-market.

Avi Kapoor

This Veracyte Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday

Wall Street analysts initiated coverage on various top stocks, including VCYT, UMAC, FISN, LTRX, and TNGX with positive ratings and price targets.

Avi Kapoor

Cathie Wood Sells Robinhood Stock, Doubles Down On This George Soros-Backed AI Stock

On Wednesday, June 10, 2026, Ark Invest sold $7.8M in Robinhood shares Wednesday while adding 141,502 shares of Kodiak AI

Shivdeep Dhaliwal

Davita, Bloomin' Brands, Compass And Other Big Stocks Moving Higher On Wednesday

Dow Jones up 500 points, DaVita Inc (DVA) shares rise after better-than-expected earnings and raised guidance. Other gaining stocks include EVC, BLMN, MNKD, FLEX, HUT, AVTX, COMP, VCYT, and SSRM.

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

178.38M

Investing Cash Flow (TTM)

-98.67M

Financing Cash Flow (TTM)

338.00K

Free Cash Flow (TTM)

165.99M

Capital Expenditure (TTM)

-12.39M

Net Change in Cash (TTM)

80.05M

Analyst Trends and Forecast

2

Apr

2

May

2

Jun

3

1

Jul

2

1

Aug

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.6

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$2.96B

PE Ratio (TTM)

30.22

PE Ratio (FWD)

23.36

PEG Ratio (TTM)

-

PS Ratio (TTM)

6.14

PB Ratio (TTM)

2.45

Earnings Yield % (TTM)

3.31%

Earnings Yield % (FWD)

4.28%

EV / EBITDA (TTM)

21.60

Price / EBITDA (TTM)

25.20

Price / Free Cash Flow (TTM)

20.77

Book Value / Share

$17.27

Company Debt

Total Debt

-

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-

Total Cash

$299.52M

Debt to Equity

0.03

Issuance of Debt (TTM)

-

Repayment of Debt (TTM)

-

Key Statistics

Open

$42.00

Close

-

Volume / Avg.

397.69K / 1.33M

Day Range

$41.04 - $42.07

52 Wk Range

28.25 - 60.91

Market Cap

$3.31B

P/E Ratio

30.22

Dividend Yield

-

Exchange

NASDAQ

RSI

34

Short Interest

10.17%

Days to Cover

4.81

About

Sector

Health Care

Industry

Biotechnology

Veracyte Inc is a genomic diagnostics company. The group empowers clinicians with the insights necessary to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. It offers tests for prostate cancer (Decipher Prostate)...

Show More

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy Veracyte (VCYT) stock?

A

You can purchase shares of Veracyte (NASDAQ:VCYT) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Veracyte (VCYT) competitors?

A

Other companies in Veracyte’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).

Q

What is the forecast, or price target, for Veracyte (VCYT) stock?

A

Veracyte has a consensus price target of $49.62.

Q

What is the current price for Veracyte (VCYT)?

A

The stock price for Veracyte (NASDAQ: VCYT) is $41.5225 last updated August 24, 2026 at 12:50 PM EDT.

Q

Does Veracyte (VCYT) pay a dividend?

A

There are no upcoming dividends for Veracyte.

Q

When is Veracyte (NASDAQ:VCYT) reporting earnings?

A

Veracyte does not have any upcoming earnings scheduled.

Q

Is Veracyte (VCYT) going to split?

A

There is no upcoming split for Veracyte.

Q

What sector and industry does Veracyte (VCYT) operate in?

A

Veracyte is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.